Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism
Objective: It is known that, in vascular parkinsonism (VP) and Parkinson’s disease (PD) it is observed shortening of steps, bradikinesia, oligokinesia, gait disorders and also…May Safinamide have a Role in Atypical Parkinsonism? A Retrospective Study in Clinical Practice
Objective: To evaluate efficacy and safety of safinamide in atypical parkinsonian syndromes. Background: Safinamide (50-100 mg) has proved efficacy as an add-on treatment to levodopa…Mutations of COX20 affect the assembly and function of complex IV causing early onset ataxia, dystonia and neuropathy
Objective: To find the causes of an early onset complex movement disorder in two sisters from a non-consanguineous family, and confirm the COX20 variants responsible for such mitochondrial…Clinical progression of Parkinson’s disease: insights from the NINDS common data elements
Objective: To synchronize data collection, the National Institute of Neurological Disorders and Stroke recommended Common Data Elements (CDEs) for use in Parkinson’s disease (PD) research.…Home validation of a smartphone-based tapping task to assess medication responsiveness in Parkinson’s disease
Objective: To validate a timed tapping task (TTT) on a smartphone to ascertain differences in OFF- and ON-phases in Parkinson’s disease (PD) in the home…The impact of motor and non-motor symptoms on walking capacity in people with Parkinson’ disease
Objective: This study aimed to evaluate the motor and non-motor factors associated with walking capacity in people with Parkinson’s disease (PwPD). Background: Walking over short…Do improvements to primary symptoms from sensory training differ in Parkinson’s disease ON vs. OFF dopaminergic medications?
Objective: Investigate whether the effects of sensory training differ ON vs. OFF medication in Parkinson’s disease using the Unified Parkinson’s Disease Rating Scale (UPDRS-III). Background:…Quantifying the incremental burden of advancing Parkinson’s disease in patients meeting the “5-2-1” Criteria: Results from an international dataset from G7 countries
Objective: Quantify the incremental clinical and humanistic burden of advancing Parkinson’s disease (PD) in patients meeting the “5-2-1” criteria. Background: The burden of PD worsens…Cooper-deficiency myeloneuropathy in Wilson´s Disease as a result of D-penicillamine treatment: A case report
Objective: To present a case of subacute combined degeneration of the spinal cord secondary to iatrogenic copper deficiency as a result of D-penicillamine therapy. Background:…Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s Disease: Longitudinal Results
Objective: To assess the change over time (1-2 years) on the Clinical Dementia Rating Sum of Boxes (CDR-SOB) in Parkinson's disease (PD). Background: The CDR-SOB…
- « Previous Page
- 1
- …
- 99
- 100
- 101
- 102
- 103
- …
- 149
- Next Page »